Cargando…

Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness

Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set...

Descripción completa

Detalles Bibliográficos
Autores principales: Senosain, Maria-Fernanda, Zou, Yong, Patel, Khushbu, Zhao, Shilin, Coullomb, Alexis, Rowe, Dianna J., Lehman, Jonathan M., Irish, Jonathan M., Maldonado, Fabien, Kammer, Michael N., Pancaldi, Vera, Lopez, Carlos F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370362/
https://www.ncbi.nlm.nih.gov/pubmed/37501683
http://dx.doi.org/10.1158/2767-9764.CRC-22-0373
_version_ 1785077923820077056
author Senosain, Maria-Fernanda
Zou, Yong
Patel, Khushbu
Zhao, Shilin
Coullomb, Alexis
Rowe, Dianna J.
Lehman, Jonathan M.
Irish, Jonathan M.
Maldonado, Fabien
Kammer, Michael N.
Pancaldi, Vera
Lopez, Carlos F.
author_facet Senosain, Maria-Fernanda
Zou, Yong
Patel, Khushbu
Zhao, Shilin
Coullomb, Alexis
Rowe, Dianna J.
Lehman, Jonathan M.
Irish, Jonathan M.
Maldonado, Fabien
Kammer, Michael N.
Pancaldi, Vera
Lopez, Carlos F.
author_sort Senosain, Maria-Fernanda
collection PubMed
description Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set of 92 patients with LUAD with data collected across different methodologies. Patients were risk-stratified using the CT-based Score Indicative of Lung cancer Aggression (SILA) tool (0 = least aggressive, 1 = most aggressive). We grouped the patients as indolent (x ≤ 0.4, n = 14), intermediate (0.4 > x ≤ 0.6, n = 27), and aggressive (0.6 > x ≤ 1, n = 52). Using Cytometry by time of flight (CyTOF), we identified subpopulations with high HLA-DR expression that were associated with indolent behavior. In the RNA sequencing (RNA-seq) dataset, pathways related to immune response were associated with indolent behavior, while pathways associated with cell cycle and proliferation were associated with aggressive behavior. We extracted quantitative radiomics features from the CT scans of the patients. Integrating these datasets, we identified four feature signatures and four patient clusters that were associated with survival. Using single-cell RNA-seq, we found that indolent tumors had significantly more T cells and less B cells than aggressive tumors, and that the latter had a higher abundance of regulatory T cells and Th cells. In conclusion, we were able to uncover a correspondence between radiomics and tumor biology, which could improve the discrimination between indolent and aggressive LUAD tumors, enhance our knowledge in the biology of these tumors, and offer novel and personalized avenues for intervention. SIGNIFICANCE: This study provides a comprehensive profiling of LUAD indolence and aggressiveness at the biological bulk and single-cell levels, as well as at the clinical and radiomics levels. This hypothesis generating study uncovers several potential future research avenues. It also highlights the importance and power of data integration to improve our systemic understanding of LUAD and to help reduce the gap between basic science research and clinical practice.
format Online
Article
Text
id pubmed-10370362
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-103703622023-07-27 Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness Senosain, Maria-Fernanda Zou, Yong Patel, Khushbu Zhao, Shilin Coullomb, Alexis Rowe, Dianna J. Lehman, Jonathan M. Irish, Jonathan M. Maldonado, Fabien Kammer, Michael N. Pancaldi, Vera Lopez, Carlos F. Cancer Res Commun Research Article Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set of 92 patients with LUAD with data collected across different methodologies. Patients were risk-stratified using the CT-based Score Indicative of Lung cancer Aggression (SILA) tool (0 = least aggressive, 1 = most aggressive). We grouped the patients as indolent (x ≤ 0.4, n = 14), intermediate (0.4 > x ≤ 0.6, n = 27), and aggressive (0.6 > x ≤ 1, n = 52). Using Cytometry by time of flight (CyTOF), we identified subpopulations with high HLA-DR expression that were associated with indolent behavior. In the RNA sequencing (RNA-seq) dataset, pathways related to immune response were associated with indolent behavior, while pathways associated with cell cycle and proliferation were associated with aggressive behavior. We extracted quantitative radiomics features from the CT scans of the patients. Integrating these datasets, we identified four feature signatures and four patient clusters that were associated with survival. Using single-cell RNA-seq, we found that indolent tumors had significantly more T cells and less B cells than aggressive tumors, and that the latter had a higher abundance of regulatory T cells and Th cells. In conclusion, we were able to uncover a correspondence between radiomics and tumor biology, which could improve the discrimination between indolent and aggressive LUAD tumors, enhance our knowledge in the biology of these tumors, and offer novel and personalized avenues for intervention. SIGNIFICANCE: This study provides a comprehensive profiling of LUAD indolence and aggressiveness at the biological bulk and single-cell levels, as well as at the clinical and radiomics levels. This hypothesis generating study uncovers several potential future research avenues. It also highlights the importance and power of data integration to improve our systemic understanding of LUAD and to help reduce the gap between basic science research and clinical practice. American Association for Cancer Research 2023-07-26 /pmc/articles/PMC10370362/ /pubmed/37501683 http://dx.doi.org/10.1158/2767-9764.CRC-22-0373 Text en © 2023 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by/4.0/This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.
spellingShingle Research Article
Senosain, Maria-Fernanda
Zou, Yong
Patel, Khushbu
Zhao, Shilin
Coullomb, Alexis
Rowe, Dianna J.
Lehman, Jonathan M.
Irish, Jonathan M.
Maldonado, Fabien
Kammer, Michael N.
Pancaldi, Vera
Lopez, Carlos F.
Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
title Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
title_full Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
title_fullStr Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
title_full_unstemmed Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
title_short Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
title_sort integrated multi-omics analysis of early lung adenocarcinoma links tumor biological features with predicted indolence or aggressiveness
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370362/
https://www.ncbi.nlm.nih.gov/pubmed/37501683
http://dx.doi.org/10.1158/2767-9764.CRC-22-0373
work_keys_str_mv AT senosainmariafernanda integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT zouyong integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT patelkhushbu integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT zhaoshilin integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT coullombalexis integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT rowediannaj integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT lehmanjonathanm integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT irishjonathanm integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT maldonadofabien integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT kammermichaeln integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT pancaldivera integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness
AT lopezcarlosf integratedmultiomicsanalysisofearlylungadenocarcinomalinkstumorbiologicalfeatureswithpredictedindolenceoraggressiveness